Senators press FDA on knockoff weight-loss drug sold online
Published
A group of senators led by Sen. Jim Banks asked FDA to crack down on sellers of retatrutide, an unapproved Eli Lilly obesity drug still in trials, marketed online as 'research use only.' Poison center reports tied to it jumped 265% early this year, and one Florida seller was charged over vials that held none of the drug.
Source: Office of Sen. Jim Banks
This is a plain-language summary. Read the original source for full details.